Kashiwagi, A., Kazuta, K., Yoshida, S., & Nagase, I. (2013). Randomized, placebo‐controlled, double‐blind glycemic control trial of novel sodium‐dependent glucose cotransporter 2 inhibitor ipragliflozin in Japanese patients with type 2 diabetes mellitus. Wiley-Blackwell.
Chicago-tyylinen lähdeviittausKashiwagi, Atsunori, Kenichi Kazuta, Satoshi Yoshida, ja Itsuro Nagase. Randomized, Placebo‐controlled, Double‐blind Glycemic Control Trial of Novel Sodium‐dependent Glucose Cotransporter 2 Inhibitor Ipragliflozin in Japanese Patients With Type 2 Diabetes Mellitus. Wiley-Blackwell, 2013.
MLA-viiteKashiwagi, Atsunori, Kenichi Kazuta, Satoshi Yoshida, ja Itsuro Nagase. Randomized, Placebo‐controlled, Double‐blind Glycemic Control Trial of Novel Sodium‐dependent Glucose Cotransporter 2 Inhibitor Ipragliflozin in Japanese Patients With Type 2 Diabetes Mellitus. Wiley-Blackwell, 2013.